Enzyme-instructed supramolecular assemblies promote intracellular boron accumulation for boron neutron capture therapy
Source abstract
Abstract
Abstract Selective accumulation of boron agents in cancer cells is of critical importance for BNCT. Here we involve enzyme-instructed supramolecular assembly (EISA) to facilitate the accumulation of a typical boron agent borylphenylalanine (BPA) in cancer cells. By covalently conjugating BPA to the phosphorylated assembly precursor, the boron-bearing precursors undergo phosphatase-catalyzed dephosphorylation to yield assembly molecules, which then self-assemble to form nanomaterials. Due to the up-regulated phosphatase activity of cancer cells, kinetic preference allows the EISA to accumulate boron in HeLa cells selectively. Interestingly, by attaching BPA on the backbone or side-chain of precursor, the boron-bearing isomers show different assembly propensity with time-dependent morphology change, which leads to the differentiated accumulation of boron inside cells. Overall, the optimized boron-bearing assembly precursor could significantly improve the boron accumulation compared with BPA in cancer cells. In this study, we have demonstrated a convenient method to introduce boron agents to cancer cells. We envision that the EISA-mediated accumulation of boron will be helpful in the design of boron agents to facilitate BNCT treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Boron Compounds in Chemistry · Boron and Carbon Nanomaterials Research · Radiopharmaceutical Chemistry and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Covalent organic polymer as a carborane carrier for imaging-facilitated boron neutron capture therapy10.1021/acsami.0c15251 ↗
2. A boron-10 nitride nanosheet for combinational boron neutron capture therapy and chemotherapy of tumor10.1016/j.biomaterials.2020.120587 ↗
3. Boron neutron capture therapy of cancer: current status and future prospects10.1158/1078-0432.CCR-05-0035 ↗
4. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer10.1186/1748-717X-7-146 ↗
5. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT)10.1016/j.jconrel.2020.11.001 ↗
6. Boron agents for neutron capture therapy10.1016/j.ccr.2019.213139 ↗
7. Synthesis of aromatic boronic acids-aldehydo boronic acids and a boronic acid analog of tyrosine10.1021/ja01537a021 ↗
8. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds10.1021/jm00316a042 ↗
9. Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism10.1126/sciadv.aaz1722 ↗
10. Treatment of malignant-melanoma by single thermal-neutron capture therapy with melanoma-seeking B-10-compound10.1016/S0140-6736(89)90567-9 ↗
11. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses10.1186/s40880-018-0297-9 ↗
12. A metabolically stable boron-derived tyrosine serves as a theranostic agent for positron emission tomography guided boron neutron capture therapy10.1021/acs.bioconjchem.9b00578 ↗
13. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT10.1007/s11060-005-9099-4 ↗
14. Advancements in tumor targeting strategies for boron neutron capture therapy10.1007/s11095-015-1718-y ↗
15. Novel carboranes with a DNA binding unit for the treatment of cancer by boron neutron capture therapy10.1002/1439-7633(20020301)3:2/3<219::AID-CBIC219>3.0.CO;2-# ↗
16. Boron neutron capture therapy: current status and future perspectives10.1002/cac2.12089 ↗
17. Amphiphilic polycarbonates from carborane-installed cyclic carbonates as potential agents for boron neutron capture therapy10.1021/acs.bioconjchem.6b00454 ↗
18. Antibody-based receptor targeting using an Fc-binding peptide-dodecaborate conjugate and macropinocytosis induction for boron neutron capture therapy10.1021/acsomega.0c01377 ↗
19. Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes10.1073/pnas.1303437110 ↗
20. Mercaptocarborane-capped gold nanoparticles: electron pools and ion traps with switchable hydrophilicity10.1021/ja203367h ↗
21. On-demand biodegradable boron nitride nanoparticles for treating triple negative breast cancer with boron neutron capture therapy10.1021/acsnano.9b04303 ↗
22. Enzymatic noncovalent synthesis10.1021/acs.chemrev.0c00306 ↗
23. Supramolecular catalysis and dynamic assemblies for medicine10.1039/C7CS00472A ↗
24. Bioinspired assembly of small molecules in cell milieu10.1039/C6CS00656F ↗
25. Taurine boosts cellular uptake of small d-peptides for enzyme-instructed intracellular molecular self-assembly10.1021/jacs.5b06181 ↗
26. A biocompatible condensation reaction for controlled assembly of nanoparticles in cells10.1038/nchem.480 ↗
27. Cancer cell death induced by the intracellular self-assembly of an enzyme-oesponsive supramolecular gelator10.1021/ja510156v ↗
28. Enzyme-instructed supramolecular self-assembly with anticancer activity10.1002/adma.201804814 ↗
29. Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative10.1021/ja904411z ↗
30. Supramolecular ‘Trojan Horse’ for nuclear delivery of dual anticancer drugs10.1021/jacs.6b12322 ↗
31. Enzyme-instructed self-assembly in biological milieu for theranostics purpose10.2174/0929867324666170921104010 ↗
32. Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems10.1038/s41467-018-07490-6 ↗
33. Narrowing the diversification of supramolecular assemblies by preorganization10.1039/C8CC01082J ↗
34. Preorganization increases the self-assembling ability and antitumor efficacy of peptide nanomedicine10.1021/acsami.0c02572 ↗
35. Branched peptides for enzymatic supramolecular hydrogelation10.1039/C7CC08421H ↗
36. Enzymatic cleavage of branched peptides for targeting mitochondria10.1021/jacs.7b11582 ↗
37. Imaging enzyme-triggered self-assembly of small molecules inside live cells10.1038/ncomms2040 ↗
38. Enzyme-instructed self-assembly for spatiotemporal profiling of the activities of alkaline phosphatases on live cells10.1016/j.chempr.2016.07.003 ↗
39. Dynamic continuum of nanoscale peptide assemblies facilitates endocytosis and endosomal escape10.1021/acs.nanolett.1c01029 ↗